Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Wiestner

Showing results (11-20 of 182) with videos related to

Pageof 19
Sort By:
Seminars in Hematology|May 1, 2022
Neal Young's journey navigating the challenges of aplastic anemia as a physician-scientist and the intricacies of medical publishing as an editorAdrian Wiestner
The Lancet. Oncology|May 25, 2016
Choosing frontline chemoimmunotherapy for CLLAdrian Wiestner
Hematology. American Society of Hematology. Education Program|February 20, 2015
BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphomaAdrian Wiestner
Blood|March 5, 2005
More ZAP for chronic lymphocytic leukemia (CLL)Adrian Wiestner
Hematology. American Society of Hematology. Education Program|December 13, 2012
Emerging role of kinase-targeted strategies in chronic lymphocytic leukemiaAdrian Wiestner
Haematologica|December 3, 2015
The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemiaAdrian Wiestner
Seminars in Hematology|February 22, 2023
Beyond SARS-CoV2, the role of viruses in the pathogenesis of hematologic malignanciesAdrian Wiestner
Oncotarget|November 22, 2017
CLL kinetics in the tumor microenvironmentClare Sun, Adrian Wiestner
Haematologica|September 2, 2019
Six-packed antibodies punch betterChristoph Rader, Adrian Wiestner
Current Opinion in Hematology|May 27, 2014
Do mantle cell lymphomas have an 'Achilles heel'?Nakhle Saba, Adrian Wiestner
Pageof 19

Showing results (11-20 of 182) with videos related to

Sort By:
Pageof 19
Seminars in Hematology|May 1, 2022
Neal Young's journey navigating the challenges of aplastic anemia as a physician-scientist and the intricacies of medical publishing as an editorAdrian Wiestner
The Lancet. Oncology|May 25, 2016
Choosing frontline chemoimmunotherapy for CLLAdrian Wiestner
Hematology. American Society of Hematology. Education Program|February 20, 2015
BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphomaAdrian Wiestner
Blood|March 5, 2005
More ZAP for chronic lymphocytic leukemia (CLL)Adrian Wiestner
Hematology. American Society of Hematology. Education Program|December 13, 2012
Emerging role of kinase-targeted strategies in chronic lymphocytic leukemiaAdrian Wiestner
Haematologica|December 3, 2015
The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemiaAdrian Wiestner
Seminars in Hematology|February 22, 2023
Beyond SARS-CoV2, the role of viruses in the pathogenesis of hematologic malignanciesAdrian Wiestner
Oncotarget|November 22, 2017
CLL kinetics in the tumor microenvironmentClare Sun, Adrian Wiestner
Haematologica|September 2, 2019
Six-packed antibodies punch betterChristoph Rader, Adrian Wiestner
Current Opinion in Hematology|May 27, 2014
Do mantle cell lymphomas have an 'Achilles heel'?Nakhle Saba, Adrian Wiestner
Pageof 19